N/A
Completed N=18
Pseudophakic Astigmatic Reduction With Verion-LenSx Arcuate Incisions
Astigmatism
Source: ClinicalTrials.gov NCT02763124 ↗
Enrolled (actual)
18
Serious AEs
0.0%
Results posted
Nov 2019
Primary outcomePrimary: Uncorrected Monocular Distance Visual Acuity — 0.14 logMAR
Summary
To assess the effectiveness of the Verion-LenSx guided arcuate incision technique to reduce astigmatism in a pseudophakic population.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Uncorrected Monocular Distance Visual Acuity |
0.14 | — |
| SECONDARY Change in Corneal Astigmatism |
1.2 | — |
| SECONDARY Change in Refractive Cylinder |
1.21 | — |
| SECONDARY Spectacle Independence at Distance |
12 | — |
Eligibility Criteria
Inclusion Criteria
- Age 40 or older
- Willing and able to provide informed consent for participation in the study.
Exclusion Criteria
-
Data sourced from ClinicalTrials.gov (NCT02763124). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.